Sound Investments. Solid Relationships.

Our Services

We provide a comprehensive array of financial services to a diverse range of corporate clients, institutional investors, and high net worth investors.

Investment Banking

Equity Research

Capital Markets

Merchant Capital

Wealth Management

Prime Brokerage

Recent
Transactions

Over 180 financings and $23.5 Billion in aggregate as Lead, Joint, or Co-Manager in 2021
db4162d30f26afe9aa3e1dd99c0f17dd6f19cc81
$6.2 Million
Registered Direct Offering
// Exclusive Placement Agent
February 2023
maxim-column-blue
PANBELA-Therapeutics-logo
$15.0 Million
Follow-On Offering
// Co-Placement Agent
January 2023
maxim-column-blue
LogicMark
$5.2 Million
Follow-On Offering
// Sole Book Running Manager
January 2023
maxim-column-blue
d78d7f23-b5a3-4348-9cf0-c336e708816b
$3.6 Million
Warrant Inducement Transaction
// Warrant Inducement Agent & Financial Advisor
January 2023
maxim-column-blue
Screen Shot 2023-01-24 at 3.11.43 PM
$7.1 Million
Registered Direct Offering
// Sole Placement Agent
January 2023
maxim-column-blue
Steakholder™ Foods Ltd. logo
$6.5 Million
Follow-On Offering
// Lead Manager
January 2023
maxim-column-blue
Screen Shot 2023-01-24 at 3.03.49 PM
$300.0 Million
SPAC Business Combination
// Sole Underwriter to Model Performance Acquisition Corp.
January 2023
maxim-column-blue
ContraFect
$7.0 Million
Registered Direct Offering
// Sole Placement Agent
December 2022
maxim-column-blue
top-ships
$13.5 Million
Follow-On Offering
// Sole Placement Agent
December 2022
maxim-column-blue
wisa logo
$7.6 Million
Follow-On Offering
// Exclusive Placement Agent
November 2022
maxim-column-blue
scPharmaceuticals_Logo-4C-NoMark-NEW
$50.0 Million
Follow-On Offering
// Co-Manager
November 2022
maxim-column-blue

Upcoming Events

Maxim Group events are hosted on our digital platform, M-Vest

There are no upcoming events at this time

Merchant Capital

Maxim Merchant Capital’s skilled specialists have significant experience in raising private capital for both late-stage and early-stage private and public companies across a range of industries; predominantly in life sciences/biotechnology. Within the biotech sector, we look for companies that address significant unmet needs and have a clear regulatory path.

Scroll to Top